Judith Dalmau

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Pediatric long COVID is characterized by myeloid CCR6 suppression and immune dysregulation.

Journal: JCI insight

Published: October 09, 2025

Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.

Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.

Journal: Med (New York, N.Y.)

Published: March 13, 2024

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.

Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.

Journal: The Journal of infectious diseases

Published: February 06, 2023

Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART.

Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART.

Journal: eLife

Published: September 27, 2022

Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs).

Altered T-cell subset distribution in the viral reservoir in HIV-1-infected individuals with extremely low proviral DNA (LoViReTs).

Journal: Journal of internal medicine

Published: March 28, 2022

Post COVID-19 Condition in Children and Adolescents: An Emerging Problem.

Post COVID-19 Condition in Children and Adolescents: An Emerging Problem.

Journal: Frontiers in pediatrics

Published: March 11, 2022

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.

Journal: Journal of virology

Published: October 20, 2021

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.

TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 07, 2020

A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.

A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 18, 2020

Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.

Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.

Journal: JAMA oncology

Published: April 10, 2020

The Genome-wide Methylation Profile of CD4+ T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression.

The Genome-wide Methylation Profile of CD4+ T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 27, 2020

Extremely low viral reservoir in treated chronically HIV-1-infected individuals.

Extremely low viral reservoir in treated chronically HIV-1-infected individuals.

Journal: EBioMedicine

Published: March 04, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026